selected publications
- Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma. Leukemia. 2022 Academic Article GET IT
-
Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma.
Transplantation and cellular therapy.
2022
Academic Article
GET IT
Times cited: 1 -
Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma.
Blood cancer journal.
2022
Academic Article
GET IT
Times cited: 1 -
The impact of anti-CD20-based therapy on hypogammaglobulinemia in patients with follicular lymphoma.
Leukemia & lymphoma.
2022
Academic Article
GET IT
Times cited: 1 -
Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2021
Academic Article
GET IT
Times cited: 28 -
Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens.
Clinical pharmacokinetics.
2021
Academic Article
GET IT
Times cited: 2 -
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups.
Blood cancer journal.
2020
Academic Article
GET IT
Times cited: 51 -
Time from diagnosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma.
Leukemia & lymphoma.
2020
Academic Article
GET IT
Times cited: 1 -
Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma.
European journal of cancer (Oxford, England : 1990).
2020
Academic Article
GET IT
Times cited: 17 -
Clinical presentation determines selection of patients for initial observation in mantle cell lymphoma.
Haematologica.
2019
Letter
GET IT
Times cited: 13 -
Targeting CD30 Using Brentuximab Vedotin in the Treatment of Hodgkin Lymphoma.
Cancer journal (Sudbury, Mass.).
2016
Review
GET IT
Times cited: 20 -
Composite angioimmunoblastic T-cell and diffuse large B-cell lymphoma.
2015
GET IT
Times cited: 2